Dulaglutide: a once-weekly GLP-1 for type 2 diabetes

Dulaglutide is a once-weekly GLP-1 receptor agonist for the treatment of type 2 diabetes. Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Professor Stephen Bain discusses its place in therapy.

Dulaglutide a once-weekly GLP-1 for type 2 diabetes

Add yours ↓
Web design and marketing agency Leamington Spa